Clatterbridge was the first cancer research centre in the UK to give an injection of the Transgene experimental immunotherapy to a patient with ...

Non-small cell lung cancer (NSCLC) remains a predominant cause of cancer-related mortality worldwide. In recent years, immune checkpoint inhibitors (ICIs) have emerged as a transformative therapeutic ...

The field of drug delivery systems is witnessing significant advancements, particularly in the context of cancer treatment. Traditional chemotherapeutics, while potent, often suffer from nonspecific ...